As of 2026-04-23, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -2.81 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.70 USD, the upside of Aldeyra Therapeutics Inc is -265.42%.
Based on its market price of 1.70 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 265.42%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.81 - -2.81 | -2.81 | -265.42% |
| P/E | (10.27) - (11.78) | (11.02) | -748.4% |
| DDM - Stable | (4.20) - (12.82) | (8.51) | -600.7% |
| DDM - Multi | (3.55) - (8.75) | (5.09) | -399.2% |
| Market Cap (mil) | 102.31 |
| Beta | 4.06 |
| Outstanding shares (mil) | 60.18 |
| Enterprise Value (mil) | 47.51 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.66% |
| Cost of Debt | 5.00% |
| WACC | 9.73% |